Climate Change Data

Environmental Metrics

ESG Focus Areas

• Corporate Governance
• Employee Well-being
• Environmental Protection
• Social Contribution
• Product Quality and Safety

Environmental Achievements

• Reduced waste by implementing resource and garbage classification.
• Implemented energy saving policies in the office, such as turning off lights and air conditioning when not in use.

Social Achievements

• Established scholarships.
• Donated rice to the Hongdao Foundation.
• Organized a volunteer activity at St. Anna's Home.
• Held a charity sale, donating proceeds to the Catholic White Yong-En Father Social Welfare Foundation.
• Implemented a corporate volunteer program.

Governance Achievements

• Passed the Corporate Governance Association's Board Effectiveness Evaluation.
• Received the 16th National Innovation Award.
• Implemented a whistleblower system.

Climate Goals & Targets

Environmental Challenges

• Maintaining sales volume of existing products.
• Ensuring timely completion of new product registration.
• Managing risks associated with new product launches.
• Government healthcare policy changes.
• Fluctuations in interest and exchange rates.

Mitigation Strategies

• Established a risk management policy and procedures.
• Developed a contingency plan for potential challenges.
• Implemented internal control systems.
• Regularly monitored and reviewed risk factors.

Supply Chain Management

Supplier Audits: 5 suppliers audited, 3 rated excellent, 2 rated good.

Responsible Procurement

• Supplier evaluation based on quality, delivery time, and service.
• Contracts with suppliers include clauses on corporate social responsibility.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI Standards

Awards & Recognition

• 16th National Innovation Award

Environmental Metrics

ESG Focus Areas

• Corporate Governance
• Employee Well-being
• Environmental Protection
• Social Responsibility
• Sustainable Development

Environmental Achievements

• Reduced carbon dioxide emissions from 19,904 kg in 2020 to 13,699 kg in 2021 at the Nangang Software Park office.
• Reduced water consumption from 628 metric tons in 2020 to 574 metric tons in 2021 at the Nangang Software Park office.
• Pharmaceutical waste with harmless properties and ingredients totaled 4.46 metric tons in 2021.

Social Achievements

• Launched the 2021 Round Island Tour to Protect Taiwan project involving employee participation in environmental protection and community engagement activities.
• Donated NT$50,000 from year-end charity sales to the Mindao Home.
• Provided health education and Baduanjin qigong sessions at the Fu-Kang Senior Center in Hualien.
• Organized a drawing selection contest and created a 2022 calendar to thank medical personnel.
• Collected used clothes and bags for donation to Africa.
• Purchased gifts from Syin-Lu Social Welfare Foundation and Taiwan Motor Neuron Disease Association for employee holidays, supporting sheltered workshops.

Governance Achievements

• Ranked among the top 5% of companies listed on Taipei Exchange in the 8th Corporate Governance Evaluation in 2021.
• President Yang, Ssu-Yuan, won the Golden Torch Award for Top Ten Managers of the Year.
• Liquid biopsy product won the Golden Torch Award for Top Ten Products of the Year.

Climate Goals & Targets

Environmental Challenges

• Difficulty in obtaining and replacing qualified raw materials.
• Potential for poor pharmaceutical quality.
• Risk of agency product recalls.
• Potential for major accidents in R&D projects.
• Concerns about corporate image, investor relations, and capital market supervision.
• Information security risks.
• Brain drain.
• Exchange rate fluctuations.
• Health insurance price adjustments.
• Impact of competitive product launches.
• Compliance challenges in the pharmaceutical industry.
• Changes in tax laws.
• COVID-19 pandemic impact.

Mitigation Strategies

• Regular supplier evaluations and sourcing alternative materials.
• Compliance with regulations, adverse drug reaction and defective product notifications, regular review and update of Customer Complaint Response Regulations, regular training and notification exercises.
• Effective inventory management, first-in, first-out principle, control quantity per batch number, regulate orders.
• Regular quality management meetings and simulated recall training.
• Strengthened communication with original manufacturers and regular meetings.
• Backup plans for R&D projects.
• Collaborative supplier selection mechanism and long-term partnerships.
• Evaluation mechanism for important tasks and risk management and control.
• R&D Project Planning and Outcome Management System and project continuation or termination evaluation mechanism.
• Maintaining media relations, investor conferences, and a spokesperson system.
• Smooth communication with competent authorities.
• Information security system and system permissions management regulations, remote backup system, education and training, monitoring network activities.
• Key talent development program and competitive benefit system.
• Regular monitoring of exchange rate trends.
• Annual procurement plan and capital needs planning.
• Participation in associations and medical policy meetings.
• Discussions with industry players and associations.
• Assessment of potential market opportunities and adjustment of product sales strategies.
• Compliance with the Pharmaceutical Affairs Act and applicable laws.
• Regular communication with associations to discuss updates to laws and regulations.
• Employee health status reporting, provision of anti-pandemic supplies, flextime/work-from-home model, online meetings and events.
• Regular confirmation of compliance with legal requirements, alignment of product specifications and production changes with law and regulations and quality assurance, consultation with competent authorities.

Supply Chain Management

Supplier Audits: Evaluated old suppliers annually; evaluated existing suppliers every three years; audited new suppliers.

Responsible Procurement

• Qualification review, on-site audits, improvement guidance, and follow-up mechanism.
• Encouraging suppliers to obtain environmental, occupational safety and health, and labor human rights certifications (OHSAS18001, ISO45001, ISO14001).
• Supplier self-assessment questionnaires.

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: GRI Standards (Core option)

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• SDG 3 (Good Health and Well-being)
• SDG 8 (Decent Work and Economic Growth)
• SDG 15 (Life on Land)

Initiatives such as health education programs, support for sheltered workshops, and environmental protection activities contribute to these goals.

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Golden Torch Awards for Top Ten Managers of the Year and Top Ten Enterprises of the Year.

Environmental Metrics

ESG Focus Areas

• Environmental sustainability
• Social inclusivity
• Corporate governance

Environmental Achievements

• Collected 806 articles of clothing and 64 bags for the Step30 project, reducing 3,385.2 kg of carbon emissions.
• Reduced carbon emissions by 2019.6 kg with stakeholders at an ESG Sustainability Camp.
• Used 118 T5 LEDs in the office, each saving 26 more watts/hour than T8 LEDs.
• Used Fairtrade certified coffee and tea, and green-marked cleaning products.

Social Achievements

• Cretrol, covered by Taiwan's national health insurance, benefited over 30,000 patients and saved the system NT$180 million.
• Supported the Step30 project by collecting clothing and bags.
• Supported local farmers by purchasing rice gift boxes.
• Donated NT$40,330 to the “Aging with You” project and NT$30,000 to Hondao Senior Citizen's Welfare Foundation.
• Provided flu vaccines and health checkups to employees and their families.
• Organized two cardiovascular health seminars benefiting 441 people.
• Added cardiovascular health education materials online.
• 100% retention rate of managerial employees and balanced gender ratio.

Governance Achievements

• Ranked in the top 5% of the 8th Corporate Governance Evaluation.
• Won the 2022 HR Asia Best Companies to Work for in Asia Award.
• Won the 1st TIRI Awards.
• Established the Sustainable Development Committee and ESG Task Force.
• Obtained 2 overseas drug licenses (Hong Kong and Myanmar).

Climate Goals & Targets

Environmental Challenges

• Supply chain disruptions due to insufficient production capacity of OEM factories and unstable raw material supply timing.
• Poor pharmaceutical quality risks.
• Risks related to R&D project accidents.
• Risks to corporate image, investor relations, and capital market supervision.
• Network and database security risks.
• Risks related to R&D project confidential information maintenance.
• Brain drain.
• Exchange rate fluctuations.
• Compliance with laws and regulations.
• Contractual risks.
• Risks related to COVID-19.
• Workplace safety and labor relations risks.

Mitigation Strategies

• Increased batch sizes, urged OEMs to purchase equipment, increased API purchase volume, early ordering, dual sourcing.
• Established real-time ADR and defective drug reporting mechanism, regular reviews, training, inventory management, simulation recycling.
• Collaborative supplier selection, task evaluation mechanism, R&D project planning and outcome management system.
• Media relations, investor conferences, spokesperson system, communication with authorities.
• Information security maintenance and control center, information security personnel training, information security alliance.
• Regular training, information security awareness sessions, access control.
• Empowerment Leadership Plan, welfare system optimization, training, employer branding, industry-academia collaboration.
• Monitoring exchange rate trends, annual procurement planning.
• Communication with associations, following up on new information, aligning with regulations, consulting experts, regular reviews, training.
• New contract database, optimized templates, strengthened review and negotiation mechanism.
• Epidemic reporting mechanism, interdepartmental response team, staggered work schedule, work from home, rapid tests, group insurance.
• Regular labor-management meetings, attention to labor laws and regulations.

Supply Chain Management

Supplier Audits: Regular inspections and audits, supplier self-assessment questionnaires.

Responsible Procurement

• Supplier assessment based on quality, service, and delivery.
• Encouraging suppliers to obtain environmental, occupational health and safety, and labor human rights certifications.

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: GRI Standards 2021, UN SDGs, Sustainable Development Best-Practice Principles for TWSE/TPEx Listed Companies, ISO 26000, UN Global Compact, SASB

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• SDG 3: Good Health and Well-being
• SDG 17: Partnerships for the Goals

Improving patients’ quality of life and becoming a strategic partner in Asia for international biotech companies.

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Top 5% in the 8th Corporate Governance Evaluation
• 2022 HR Asia Best Companies to Work for in Asia Award
• 1st TIRI Awards

Environmental Metrics

ESG Focus Areas

• Environmental Sustainability
• Social Responsibility
• Corporate Governance

Environmental Achievements

• Adopted black soybean fields in Syuejia, Tainan, supporting eco-friendly farming and restoring soil health
• Printed 4,100 copies of photocopying paper and desktop calendars using FSC™ certified paper
• 0 incidents of violating environmental laws and regulations

Social Achievements

• Supported 112 charity gift boxes for the Saint Joseph Social Welfare Foundation
• Provided 100 doses of influenza vaccine free of charge to employees and subsidized flu vaccinations for family members
• Implemented the EAP system in 2023, caring for employees’ physical and mental health
• Organized the “Free Public Health Seminar for the Heart of the Nation Campaign” 5 times, benefiting a total of 769 people
• Supported the Taiwan Stroke Association in producing one “Educational Video for Elderly and Disabled Stroke Patients”

Governance Achievements

• Initiated the “Golden Chick Project,” successfully acquiring 51% equity in Chuang Yi Biotech.
• President Ssu-Yuan Yang received the 20th National Brand Yushan Award for Exceptional Corporate Leadership
• Ranked in the top 6–20% of the 10th Corporate Governance Evaluation
• Employee turnover rate in 2023 decreased by 2% compared to the previous year
• Held 8 Board of Directors meetings, with an average attendance rate of 98.21%

Climate Goals & Targets

Environmental Challenges

• Supply chain disruptions due to uncertain delivery times from European raw material suppliers
• Poor quality of pharmaceuticals
• Product stock-outs
• Major accident at self-operated CDMO facility
• Regulatory penalties
• Contractual disputes
• Information security risks

Mitigation Strategies

• Attempt to sign long-term contracts with suppliers; seek alternative material sources
• Establish mechanisms for adverse drug reaction and defective product reporting; regular training and notification exercises; effective inventory management
• Allocate inventory before stock-outs; anticipate quantity increases; send stock-out notifications
• Establish a third-party vendor selection mechanism; establish an evaluation mechanism for important tasks
• Regularly track amendments to operation-related regulations; conduct internal training
• Legal department proposes preemptive solutions; continuously review company contracts
• Establish a cybersecurity team; implement annual cybersecurity training programs

Supply Chain Management

Supplier Audits: 15 suppliers underwent annual evaluations; 100% positive results

Responsible Procurement

• Supplier Code of Conduct
• Environmental and social responsibility standards

Climate-Related Risks & Opportunities

Physical Risks

• Extreme weather events disrupting supplier production or transportation
• Raw material price increases due to extreme climate events
• Decreased product sales due to extreme climate events

Transition Risks

• Increased operational costs due to carbon fees or total emission controls
• Increased raw material costs due to higher carbon emission management requirements
• Decreased customer loyalty due to failure to meet customers’ environmental demands
• Revenue decline due to customer loss
• Corporate image damage

Opportunities

• Transition to green packaging
• Industrial upgrade
• Government policy support

Reporting Standards

Frameworks Used: GRI Standards, SASB, TCFD, UNGC, ISO 26000

Certifications: Null

Third-party Assurance: Afnor Asia, Ltd.

UN Sustainable Development Goals

• SDG 3 (Good Health and Well-being)
• SDG 8 (Decent Work and Economic Growth)
• SDG 11 (Sustainable Cities and Communities)
• SDG 13 (Climate Action)
• SDG 15 (Life on Land)

Initiatives contribute to these goals through health education seminars, support for local revitalization, eco-friendly farming, carbon reduction efforts, and employee well-being programs.

Sustainable Products & Innovation

• Tyrvaya nasal spray for dry eye disease

Awards & Recognition

• 20th National Brand Yushan Award for Exceptional Corporate Leadership